Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status
2017 ◽
Vol 49
(4)
◽
pp. 981-989
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7032-7032
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 6
(20)
◽
pp. 405-405
◽
Keyword(s):
2018 ◽
Vol 10
(7)
◽
pp. 4169-4177
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 11
(4)
◽
pp. S122
◽
Keyword(s):